The Archer-Daniels-Midland Company
17
3
3
10
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
5.9%
1 terminated/withdrawn out of 17 trials
90.9%
+4.4% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 10 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (17)
Study to Assess the Effect of Multistrain Probiotic on the Immune Response to the Influenza Vaccination
Role: lead
Digestion of Gluten in the Presence of Enzymes
Role: lead
Evaluation of Soy Isoflavones on Skin Ageing Parameters
Role: lead
A Study to Assess the Effect of a Probiotic on Upper Respiratory Tract Infections in Healthy Children
Role: lead
The Efficacy of a Probiotic for Antibiotic Associated Gastrointestinal Symptoms
Role: lead
Study to Evaluate the Efficacy of a Probiotic in Infantile Colic Symptoms Relief
Role: lead
The Efficacy of a Probiotic for Functional Constipation (FC)
Role: lead
Safety and Efficacy of a Probiotic Supplement in IBS-D
Role: lead
Study of Efficacy of a Probiotic and Postbiotic in Overweight and Obese Individuals
Role: lead
Pilot Study to Assess the Effect of a Probiotic Blend on Moderate Self-reported Anxiety.
Role: lead
Pilot Study to Assess the Effect of a Postbiotic Blend on Moderate Self-reported Anxiety
Role: lead
Efficacy of Two Enzyme Cocktails in Healthy Adults
Role: lead
Changes in Amino Acid Absorption After Adding a Probiotic to an Acute Protein Feeding
Role: lead
Effect of a Multi-strain Probiotic on Recurrent Vulvovaginal Candidiasis
Role: lead
Determination of the Safety and Efficacy of Two Probiotic Strains
Role: lead
Study of Safety and Efficacy of a Probiotic and Postbiotic in Overweight Individuals
Role: lead
Probiotics and Influenza Vaccination Response
Role: lead
All 17 trials loaded